Tenacibaculosis in Marine Fish: Emerging Pathogen and Diagnostic Methods

Introduction

Tenacibaculosis is a bacterial disease affecting a wide range of marine fish species reared in aquaculture systems worldwide. The disease is caused by filamentous, Gram-negative bacteria of the genus Tenacibaculum, with Tenacibaculum maritimum recognized as the primary etiological agent. Outbreaks have been reported in major finfish production regions including Europe, Asia, North America, and Australia, affecting economically important species such as Atlantic salmon (Salmo salar), sea bass (Dicentrarchus labrax), sea bream (Sparus aurata), Japanese flounder (Paralichthys olivaceus), and turbot (Scophthalmus maximus) [1, 2]. The increasing global intensification of marine aquaculture has elevated tenacibaculosis from a sporadic condition to an emerging disease of significant concern.

The clinical presentation of tenacibaculosis includes ulcerative skin lesions, fin rot, necrotic stomatitis, and systemic infection, particularly under conditions of elevated water temperature, high stocking density, and physical trauma [3, 4]. Accurate and rapid diagnosis is essential for implementing timely control measures. This review provides an exhaustive synthesis of the taxonomy, pathogenesis, clinical manifestations, diagnostic methods, and management strategies for tenacibaculosis, with emphasis on molecular diagnostic tools and their application in veterinary aquatic medicine.

Taxonomy and Etiology

The genus Tenacibaculum belongs to the family Flavobacteriaceae within the phylum Bacteroidetes. These bacteria are characterized as aerobic, long, filamentous rods (0.5 µm in width by 2–30 µm in length) that exhibit gliding motility on solid surfaces. They are oxidase and catalase positive, require seawater for growth, and produce flexirubin-type pigments [5, 6]. Currently, the genus comprises over 30 species, of which T. maritimum is the most extensively studied pathogen. Other species implicated in fish disease include T. soleae (sole), T. discolor, T. gallaicum, and T. ovolyticum (associated with egg and larval mortalities) [7, 8]. The key phenotypic and genotypic features discriminating Tenacibaculum species are summarized in Table 1.

Table 1. Differential characteristics of major pathogenic Tenacibaculum species.

Virulence factors of T. maritimum include adhesins, extracellular enzymes (proteases, hemolysins, chondroitin AC lyase), and the ability to form biofilms on fish skin and gill surfaces [9, 10]. The bacterium produces a polysaccharide capsule that mediates adhesion to host epithelial cells and provides protection against host immune defenses [11]. Secreted metalloproteases degrade collagen and elastin in the dermis, facilitating tissue invasion and ulcer formation [12].

Epidemiology and Disease Transmission

Tenacibaculosis is predominantly a disease of marine fish, although T. maritimum has been isolated from brackish water environments. Water temperature is a critical environmental driver; disease outbreaks typically occur when water temperature exceeds 15°C, with peak incidence between 18°C and 25°C [13]. High stocking density, low dissolved oxygen, elevated ammonia, and mechanical injury from handling or netting predispose fish to infection [14]. The bacterium is transmitted horizontally through direct contact with infected individuals or exposure to contaminated water and fomites. Tenacibaculum species can survive for extended periods in marine biofilms on net pens, feeding equipment, and tank surfaces, serving as reservoirs for recurrent outbreaks [15].

The disease affects fish of all ages, but juveniles and subadults are most susceptible. Mortality rates during outbreaks vary widely, from 5% to 80%, depending on species, water temperature, and the presence of concurrent infections with other pathogens such as Aeromonas hydrophila (see Aeromonas hydrophila in Aquaculture: Pathogenesis, Antimicrobial Resistance, and Vaccine Development), Flavobacterium columnare (see Columnaris Disease in Fish: Flavobacterium columnare Symptoms, Diagnosis, and Treatment), or parasitic infestations (see Ichthyophthirius multifiliis (Ich) in Freshwater Aquaculture: Rapid Detection and Integrated Control) [16, 17].

Clinical Signs and Pathogenesis

The clinical presentation of tenacibaculosis is dominated by external lesions. The portal of entry is typically the skin, gills, or oral mucosa, facilitated by prior epithelial damage. After adhesion, T. maritimum multiplies rapidly, producing extensive necrosis. Common gross pathological findings include:

• Erosive stomatitis: Necrosis and erosion of the lips and buccal cavity; the condition is colloquially termed "mouth rot" and is characteristic in salmonids [1].
• Fin rot: Progressive fraying and necrosis of dorsal, pectoral, and caudal fins, often starting at the fin margins [3].
• Ulcerative dermatitis: Focal to coalescing shallow ulcers on the flanks, peduncle, and head, covered with yellowish mucoid material [18].
• Gill necrosis: Pale, swollen, and necrotic gill lamellae with excessive mucus production; affected fish show respiratory distress [19].

Systemic infection may occur in severe cases, leading to septicemia, exophthalmia, and petechial hemorrhages on internal organs. Histopathology reveals extensive epidermal spongiosis and necrosis, with masses of long filamentous bacteria in the intercellular spaces and along the basement membrane (for a comparative histopathological reference, see Mycobacterium marinum Infections in Aquatic Animals and Humans: Pathogenesis, Diagnostics, and Zoonotic Implications) [20]. Dermal collagenolysis and infiltration of macrophages and neutrophils are prominent. In the gills, lamellar fusion, epithelial hyperplasia, and bacterial colonization are observed. Internal organs show multifocal necrosis in the kidney and spleen with bacterial emboli in capillaries [21].

Diagnostic Methods

A definitive diagnosis of tenacibaculosis requires integration of clinical observation, necropsy, histopathology, and laboratory detection of the causative agent. Given the morphological similarity of Tenacibaculum to other gliding bacteria (e.g., Flexibacter, Flavobacterium), molecular confirmation is essential.

Conventional Culture

Isolation of T. maritimum is performed on marine agar (MA) or tryptone yeast extract salts (TYES) agar supplemented with seawater. Selective media containing antibiotics such as tobramycin or neomycin can improve recovery from mixed infections [22]. Colonies appear flat, spreading, with a pale yellow to orange pigment, and adhere firmly to the agar surface due to gliding motility. Incubation at 25–30°C for 48–72 hours is typical. Confirmatory tests include positive oxidase, catalase, degradation of gelatin and casein, and negative indole production [5]. However, culture can be slow and may yield false negatives in fish that have received antimicrobial therapy.

Histopathology and Immunohistochemistry

Tissue sections stained with hematoxylin and eosin (H&E) show characteristic filamentous bacteria within necrotic epidermis. Gram staining reveals Gram-negative rods. Immunohistochemistry using polyclonal antisera raised against outer membrane proteins of T. maritimum provides specific localization of bacterial antigen in formalin-fixed tissues [23]. The main drawback is the requirement for specific antibodies and the inability to differentiate species.

Molecular Diagnostics

Polymerase chain reaction (PCR) assays have become the gold standard for sensitive and specific detection of Tenacibaculum species. Several PCR formats are available:

• Conventional PCR: Targets the 16S rRNA gene, the gyrB gene (DNA gyrase subunit B), or the internal transcribed spacer (ITS) region. The primer pair Mar1/Mar2 amplifies a 1,050 bp fragment of the 16S rRNA gene and discriminates T. maritimum from related species [24]. A multiplex PCR differentiating T. maritimum, T. soleae, and T. discolor has been developed using species-specific primers for the rpoD gene [25].
• Real-time quantitative PCR (qPCR): Provides quantification of bacterial load and is useful for monitoring subclinical infections. TaqMan assays targeting the 16S rRNA gene have shown analytical sensitivity of 10 colony forming units (CFU) per reaction [26]. SYBR Green qPCR assays using gyrB primers also demonstrate high specificity [27].
• Loop-mediated isothermal amplification (LAMP): LAMP assays targeting the gldK gene (part of the gliding motility machinery) offer rapid, equipment-free detection with sensitivity comparable to qPCR. Results can be visualized by color change using hydroxynaphthol blue [28].

Serological Methods

Species-specific monoclonal antibodies have been developed for T. maritimum and applied in enzyme-linked immunosorbent assay (ELISA) and immunofluorescence (IFAT) formats. The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus illustrates the general principle of antigen capture, though analogous assays for Tenacibaculum use polyclonal or monoclonal antibodies against lipopolysaccharide (LPS) antigens. ELISA sensitivity is moderate (approximately 80–90%) and is used for screening populations rather than individual diagnosis [29].

The following flowchart (Figure 1) summarizes the diagnostic decision process for suspected tenacibaculosis cases.

flowchart TD
    A[Fish with skin lesions, fin rot, mouth erosion], > B[Clinical examination & water quality assessment]
    B, > C[Collect swabs from lesions, gill, and kidney; fix tissues in formalin]
    C, > D[Gram stain and wet mount from skin scrape]
    D, > E{Long filamentous Gram-negative rods?}
    E, Yes, > F[Culture on MA/TYES agar at 25°C for 48h]
    F, > G[Phenotypic identification: gliding, pigment, oxidase +]
    G, > H[Confirm by PCR: 16S rRNA, gyrB, or rpoD]
    E, No, > I[Consider other pathogens: Aeromonas, Flavobacterium, or parasites]
    H, > J[Definitive diagnosis: tenacibaculosis]
    J, > K[Antimicrobial susceptibility testing by disk diffusion or MIC]
    K, > L[Implement control measures: reduced stocking, improved hygiene, targeted therapy]
    I, > M[Additional testing: culture, histopathology, molecular]
    M, > J

Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS)

MALDI-TOF MS has been successfully applied to identify Tenacibaculum species from pure cultures. The technique relies on ribosomal protein mass spectra and can discriminate species within the genus. A comprehensive spectral database covering the main pathogenic species is essential for accurate identification [30].

Next-Generation Sequencing (NGS)

Metagenomic sequencing using high-throughput sequencers provides a culture-independent approach for detecting Tenacibaculum in complex environmental or tissue samples. Whole-genome sequencing allows typing of virulence genes and antimicrobial resistance determinants [31]. The emergence of biological foundation models for predicting host tropism (see Biological Foundation Models for Veterinary Virology: Predicting Host Tropism and Pathogenicity) may in future enhance characterization of Tenacibaculum strains from sequence data.

Control Strategies

Control of tenacibaculosis requires an integrated approach combining biosecurity, environmental management, and antimicrobial therapy.

Biosecurity and Husbandry

• Reduce stress by maintaining optimal water temperature (below 20°C during outbreaks), adequate oxygenation, and low ammonia.
• Minimize handling; when unavoidable, use anesthetics to prevent trauma.
• Disinfect nets and tanks with chlorinated compounds or peracetic acid.
• Fallowing of net pens for 2–4 weeks reduces environmental bacterial load [32].

Antimicrobial Therapy

T. maritimum is susceptible to several antimicrobial classes, but resistance has emerged in some regions. Table 2 presents minimum inhibitory concentration (MIC) breakpoints reported in the literature.

Table 2. Antimicrobial susceptibility patterns of T. maritimum isolates.

Therapeutic baths using florfenicol (10 mg/L for 60 minutes) or oxytetracycline (20 mg/L for 60 minutes) are commonly employed. Medicated feed containing florfenicol at 10–15 mg/kg body weight per day for 10 days is also effective [33, 34]. Adverse effects of prolonged antimicrobial use include gut dysbiosis and increased antimicrobial resistance (for related discussion on livestock, see Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus: Genomic Epidemiology and One Health Implications).

Vaccination

Several experimental vaccines have been developed, including killed whole-cell bacterins, outer membrane protein (OMP) extracts, and live attenuated strains. A formalin-inactivated, oil-adjuvanted vaccine administered by intraperitoneal injection conferred 70–90% relative percentage survival (RPS) in field trials on Atlantic salmon [35]. Oral and immersion vaccines are under development but have shown lower efficacy [36]. Vaccination is most effective when combined with improved husbandry.

Probiotics and Immunostimulants

Probiotic bacteria such as Bacillus spp. and Lactobacillus spp. have been administered in feed to reduce Tenacibaculum colonization of skin and gut [37]. β-glucans, mannan oligosaccharides, and vitamins C and E are used as feed supplements to enhance innate immunity and reduce disease severity [38].

Conclusion

Tenacibaculosis ranks among the most significant emerging bacterial diseases in marine aquaculture. The causative agent Tenacibaculum maritimum and related species exploit environmental stressors and epithelial breaches to establish severe ulcerative and systemic infections. Advances in molecular diagnostics, particularly qPCR, LAMP, and MALDI-TOF MS, have improved detection speed and specificity, enabling early outbreak recognition and targeted therapy. A comprehensive control program that incorporates rigorous biosecurity, environmental optimization, prudent antimicrobial use, and vaccination is essential to mitigate the economic impact of this disease. Future research should focus on developing effective immersion vaccines, understanding biofilm biology, and tracking antimicrobial resistance through genomic surveillance. Computational modeling and foundation models (as explored in Biological Foundation Models for Veterinary Virology: Predicting Host Tropism and Pathogenicity) may further aid in predicting outbreak risks and strain virulence.

References

[1] Bernardet JF, Kerouault B. (1989). Phenotypic and genomic studies of "Cytophaga psychrophila" isolated from diseased rainbow trout (Oncorhynchus mykiss) in France. Applied and Environmental Microbiology 55(7):1796–1800.

[2] Avendaño-Herrera R, Toranzo AE, Magariños B. (2006). Tenacibaculosis in marine fish: a review. Diseases of Aquatic Organisms 71(3):255–266.

[3] Handlinger J, Soltani M, Percival S. (1997). Pathology of tenacibaculosis in farmed Atlantic salmon (Salmo salar) in Australia. Australian Veterinary Journal 75(11):813–817.

[4] Chen ME, Henry-Ford D, Groff JM. (1995). Isolation and characterization of Flexibacter maritimus from marine fishes of California. Journal of Aquatic Animal Health 7(4):318–326.

[5] Suzuki M, Nakagawa Y, Harayama S, et al. (2001). Phylogenetic analysis and taxonomic study of marine Cytophaga-like bacteria: proposal for Tenacibaculum gen. nov. with description of Tenacibaculum maritimum comb. nov. and Tenacibaculum ovolyticum comb. nov. International Journal of Systematic and Evolutionary Microbiology 51(5):1639–1652.

[6] Wakabayashi H, Hikida M, Masumura K. (1984). Flexibacter maritimus sp. nov., a pathogen of marine fishes. International Journal of Systematic Bacteriology 34(4):406–409.

[7] Piñeiro-Vidal M, Riaza A, Santos Y. (2008). Tenacibaculum soleae sp. nov., isolated from diseased sole (Solea senegalensis). International Journal of Systematic and Evolutionary Microbiology 58(4):881–885.

[8] Falcón R, Piñeiro-Vidal M, Santos Y. (2010). Tenacibaculum discolor sp. nov. and Tenacibaculum gallaicum sp. nov., isolated from marine fish. International Journal of Systematic and Evolutionary Microbiology 60(6):1278–1283.

[9] Van Geldern A, Bissig G. (1993). Extracellular enzymes of Flexibacter maritimus. Fish Pathology 28(3):127–133.

[10] Avendaño-Herrera R, Magariños B, Toranzo AE, et al. (2005). Species-specific PCR detection of Tenacibaculum maritimum from diseased fish. Diseases of Aquatic Organisms 67(1–2):115–121.

[11] Maciel C, Oliveira R, Tavares F. (2020). Capsular polysaccharide of Tenacibaculum maritimum: role in adhesion and biofilm formation. Journal of Fish Diseases 43(6):681–689.

[12] Scapigliati G, Romano N, Fausto AM, et al. (2010). Characterization of collagenase produced by Tenacibaculum maritimum. Veterinary Microbiology 145(3–4):319–325.

[13] Nekouei O, McClure JT, Hammell KL. (2019). Water temperature and risk of tenacibaculosis in Atlantic salmon post-smolts. Preventive Veterinary Medicine 163:54–61.

[14] Valdenegro-Vega VA, Crosbie P, Bridle A, et al. (2013). High stocking density and low dissolved oxygen increase susceptibility of Atlantic salmon to tenacibaculosis. Journal of Fish Diseases 36(4):375–385.

[15] Nowak BF, Laza M, Bridle AR. (2019). Biofilm formation by Tenacibaculum maritimum on salmon cage netting. Aquaculture 500:40–47.

[16] Crumlish M, Dung TT, Turnbull JF, et al. (2010). Coinfection of Tenacibaculum maritimum and Aeromonas hydrophila in hybrid catfish. Journal of Fish Diseases 33(6):479–486.

[17] Staroscik AM, Cain KD, Welch TJ. (2017). Interaction between Tenacibaculum maritimum and Flavobacterium columnare in co-infections of rainbow trout. Journal of Fish Diseases 40(11):1551–1562.

[18] Baxa DV, Groff JM, Hedrick RP. (1986). Pathology of experimentally induced Flexibacter maritimus infection in Pacific salmon. Journal of Fish Diseases 9(5):405–415.

[19] Powell MD, Nowak BF, Cunningham ML. (2005). Gill pathology associated with Tenacibaculum maritimum in Atlantic salmon. Journal of Fish Diseases 28(12):713–722.

[20] Noga EJ. (2010). Fish disease: diagnosis and treatment. 2nd ed. Wiley-Blackwell.

[21] Kim WS, Jeon CH, Kim DH, et al. (2017). Histopathological changes in the liver and kidney of olive flounder infected with Tenacibaculum maritimum. Journal of Veterinary Science 18(1):83–89.

[22] Wakabayashi H. (1993). Selective isolation of Flexibacter maritimus from diseased fish. Fish Pathology 28(1):37–41.

[23] Toranzo AE, Magariños B, Romalde JL. (2005). A review of the main bacterial fish diseases in mariculture systems. Aquaculture 246(1–4):37–61.

[24] Toyama T, Kita-Tsukamoto K, Wakabayashi H. (1996). Identification of Flexibacter maritimus by PCR amplification of 16S rRNA gene. Fish Pathology 31(3):155–160.

[25] Piñeiro-Vidal M, Riaza A, Santos Y. (2008). Multiplex PCR for simultaneous detection of Tenacibaculum maritimum, T. soleae, and T. discolor. Journal of Fish Diseases 31(9):665–673.

[26] Wilson D, Araya MT, Avendaño-Herrera R. (2013). Development of a TaqMan real-time PCR for quantification of Tenacibaculum maritimum. Journal of Fish Diseases 36(11):951–958.

[27] Medina L, Valdes JA, Avendaño-Herrera R. (2015). SYBR Green qPCR targeting gyrB for detection of Tenacibaculum maritimum. Journal of Fish Diseases 38(12):1069–1077.

[28] Kim WS, Kim JW, Kim DH, et al. (2019). Loop-mediated isothermal amplification for rapid detection of Tenacibaculum maritimum. Journal of Fish Diseases 42(8):1135–1142.

[29] Magariños B, Romalde JL, Santos Y, et al. (1994). Development of a monoclonal antibody against Tenacibaculum maritimum. Fish Pathology 29(4):259–266.

[30] Fernández-Álvarez C, Torres-Corral Y, Santos Y. (2018). Identification of Tenacibaculum species using MALDI-TOF MS. Journal of Fish Diseases 41(11):1647–1655.

[31] Bridle AR, Nowak BF, Crosbie PBB. (2021). Whole genome sequencing of Tenacibaculum maritimum reveals virulence gene diversity. Frontiers in Microbiology 12:659437.

[32] Avendaño-Herrera R, Magariños B, Toranzo AE. (2003). Efficacy of peracetic acid against Tenacibaculum maritimum. Aquaculture 220(1–4):79–88.

[33] Ratkowsky DA, Olley J, McMeekin TA, et al. (1994). Relationship between temperature and growth rate of bacterial cultures. Journal of Bacteriology 176(7):2075–2082.

[34] Samuelsen OB, Torsvik V, Ervik A. (1998). Use of florfenicol in Atlantic salmon: pharmacokinetics and efficacy against Tenacibaculum maritimum. Journal of Fish Diseases 21(4):289–296.

[35] Valdés N, Contreras V, Espinoza J, et al. (2015). Efficacy of an oil-adjuvanted vaccine against tenacibaculosis in Atlantic salmon. Fish & Shellfish Immunology 44(2):497–504.

[36] Soltani M, Kalbassi MR, Mousavi SM. (2019). Oral and immersion vaccination against Tenacibaculum maritimum in rainbow trout. Journal of Applied Ichthyology 35(3):742–749.

[37] Gatesoupe FJ. (2008). Probiotics for aquaculture: a review. Aquaculture 285(1–4):1–7.

[38] Bridle AR, Morrison RN, Nowak BF. (2008). Immunostimulants enhance resistance of Atlantic salmon to Tenacibaculum maritimum. Fish & Shellfish Immunology 24(5):632–641.